why Definitive Healthcare Corp [DH] is a Good Choice for Investors After New Price Target of $9.25

Definitive Healthcare Corp [NASDAQ: DH] slipped around -1.9 points on Wednesday, while shares priced at $5.35 at the close of the session, down -26.21%.

Compared to the average trading volume of 500.36K shares, DH reached a trading volume of 5266608 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Definitive Healthcare Corp [DH]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for DH shares is $9.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on DH stock is a recommendation set at 2.38. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Morgan Stanley have made an estimate for Definitive Healthcare Corp shares, keeping their opinion on the stock as Equal-Weight, with their previous recommendation back on May-09-24. The new note on the price target was released on January 17, 2024, representing the official price target for Definitive Healthcare Corp stock.

The Average True Range (ATR) for Definitive Healthcare Corp is set at 0.49, with the Price to Sales ratio for DH stock in the period of the last 12 months amounting to 2.46. The Price to Book ratio for the last quarter was 0.73, with the Price to Cash per share for the same quarter was set at 2.51. Price to Free Cash Flow for DH in the course of the last twelve months was 15.40 with Quick ratio for the last quarter at 2.21.

How has DH stock performed recently?

Definitive Healthcare Corp [DH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -23.24. With this latest performance, DH shares dropped by -31.93% in over the last four-week period, additionally sinking by -28.57% over the last 6 months – not to mention a drop of -46.87% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for DH stock in for the last two-week period is set at 24.54, with the RSI for the last a single of trading hit 20.11, and the three-weeks RSI is set at 28.29 for Definitive Healthcare Corp [DH]. The present Moving Average for the last 50 days of trading for this stock 7.72, while it was recorded at 6.79 for the last single week of trading, and 8.50 for the last 200 days.

Definitive Healthcare Corp [DH]: Deeper insight into the fundamentals

Definitive Healthcare Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.21 and a Current Ratio set at 2.21.

Earnings analysis for Definitive Healthcare Corp [DH]

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for DH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Definitive Healthcare Corp go to 47.20%.

Insider trade positions for Definitive Healthcare Corp [DH]

The top three institutional holders of DH stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in DH stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in DH stock with ownership which is approximately 5.8386%.